Date: Feb 19, 2022
MODERNA VACCINE INTELLECTUAL PROPERTY CLAIMS
The pharmaceutical company Moderna and the National Institute of Health of United States are now in a dispute over who deserves credit for inventing the coronavirus vaccine. Moderna has filed the related patent application at the United States Patent and Trademark Office, without mentioning the names of three United States government scientists who took a significant part in developing the vaccine which has also generated significant revenue for the company. As a result, the institute, as the alleged co-owner of the patent for the vaccine, is seeking to defend its claim. While, Moderna appreciates its collaboration with the NIH scientists and will continue to work with them to help patients, it does not consider itself bound to mention the Institute’ scientists in its patent application.
The patent application has been filed but the patent has not been issued. If the current dispute results in co-ownership of the vaccine between Moderna and the NIH, the availability and price of the vaccine worldwide would be affected.
The pharmaceutical company Moderna and the National Institute of Health of United States are now in a dispute over who deserves credit for inventing the coronavirus vaccine. Moderna has filed the related patent application at the United States Patent and Trademark Office, without mentioning the names of three United States government scientists who took a significant part in developing the vaccine which has also generated significant revenue for the company.
